ML19331A674

From kanterella
Jump to navigation Jump to search
Shine Medical Technologies, LLC Supplement 1 to Final Safety Analysis Report, Chapter 10, Experimental Facilities
ML19331A674
Person / Time
Site: SHINE Medical Technologies, 99902034
Issue date: 11/14/2019
From:
SHINE Medical Technologies
To:
Office of Nuclear Reactor Regulation
Shared Package
ML19331A832 List:
References
2019-SMT-0119
Download: ML19331A674 (6)


Text

Chapter 10 - Experimental Facilities Table of Contents CHAPTER 10 EXPERIMENTAL FACILITIES TABLE OF CONTENTS Section Title Page 10.1

SUMMARY

DESCRIPTION ............................................................................... 10.1-1

10.2 REFERENCES

................................................................................................... 10.2-1 SHINE Medical Technologies 10-i Rev. 0

Chapter 10 - Experimental Facilities List of Tables LIST OF TABLES Number Title None SHINE Medical Technologies 10-ii Rev. 0

Chapter 10 - Experimental Facilities List of Figures LIST OF FIGURES Number Title None SHINE Medical Technologies 10-iii Rev. 0

Chapter 10 - Experimental Facilities Acronyms and Abbreviations ACRONYMS AND ABBREVIATIONS Acronym/Abbreviation Definition None SHINE Medical Technologies 10-iv Rev. 0

Chapter 10 - Experimental Facilities Summary Description CHAPTER 10 - EXPERIMENTAL FACILITIES 10.1

SUMMARY

DESCRIPTION The SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors:

Format and Content (USNRC, 1996) and the Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors (USNRC, 2012).

SHINE Medical Technologies 10.1-1 Rev. 0

Chapter 10 - Experimental Facilities References

10.2 REFERENCES

USNRC, 1996. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February 1996.

USNRC, 2012. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 17, 2012.

SHINE Medical Technologies 10.2-1 Rev. 0